Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 5 |
NetGPI | no | yes: 0, no: 5 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0016020 | membrane | 2 | 6 |
GO:0110165 | cellular anatomical entity | 1 | 6 |
Related structures:
AlphaFold database: Q4QIL1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 160 | 162 | PF00675 | 0.526 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.492 |
CLV_NRD_NRD_1 | 213 | 215 | PF00675 | 0.471 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.459 |
CLV_NRD_NRD_1 | 294 | 296 | PF00675 | 0.550 |
CLV_PCSK_FUR_1 | 158 | 162 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 193 | 195 | PF00082 | 0.561 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.348 |
CLV_PCSK_KEX2_1 | 220 | 222 | PF00082 | 0.487 |
CLV_PCSK_PC1ET2_1 | 193 | 195 | PF00082 | 0.545 |
CLV_PCSK_SKI1_1 | 190 | 194 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 288 | 292 | PF00082 | 0.482 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.506 |
DEG_SPOP_SBC_1 | 226 | 230 | PF00917 | 0.653 |
DOC_ANK_TNKS_1 | 58 | 65 | PF00023 | 0.440 |
DOC_PP4_FxxP_1 | 203 | 206 | PF00568 | 0.666 |
DOC_PP4_FxxP_1 | 60 | 63 | PF00568 | 0.509 |
DOC_USP7_MATH_1 | 135 | 139 | PF00917 | 0.695 |
DOC_USP7_MATH_1 | 226 | 230 | PF00917 | 0.673 |
DOC_USP7_MATH_1 | 256 | 260 | PF00917 | 0.760 |
DOC_USP7_MATH_1 | 267 | 271 | PF00917 | 0.593 |
DOC_USP7_MATH_1 | 276 | 280 | PF00917 | 0.632 |
DOC_USP7_MATH_1 | 42 | 46 | PF00917 | 0.550 |
DOC_USP7_MATH_1 | 84 | 88 | PF00917 | 0.658 |
DOC_WW_Pin1_4 | 145 | 150 | PF00397 | 0.693 |
DOC_WW_Pin1_4 | 230 | 235 | PF00397 | 0.755 |
DOC_WW_Pin1_4 | 250 | 255 | PF00397 | 0.641 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.470 |
LIG_14-3-3_CanoR_1 | 227 | 236 | PF00244 | 0.734 |
LIG_14-3-3_CanoR_1 | 46 | 52 | PF00244 | 0.484 |
LIG_14-3-3_CterR_2 | 295 | 299 | PF00244 | 0.771 |
LIG_BRCT_BRCA1_1 | 34 | 38 | PF00533 | 0.572 |
LIG_BRCT_BRCA1_1 | 77 | 81 | PF00533 | 0.498 |
LIG_deltaCOP1_diTrp_1 | 90 | 97 | PF00928 | 0.652 |
LIG_EH_1 | 40 | 44 | PF12763 | 0.560 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.498 |
LIG_LIR_Gen_1 | 50 | 60 | PF02991 | 0.340 |
LIG_LIR_Nem_3 | 47 | 52 | PF02991 | 0.459 |
LIG_RPA_C_Fungi | 156 | 168 | PF08784 | 0.413 |
LIG_RPA_C_Fungi | 215 | 227 | PF08784 | 0.521 |
LIG_SH2_CRK | 52 | 56 | PF00017 | 0.409 |
LIG_SH2_GRB2like | 25 | 28 | PF00017 | 0.729 |
LIG_SH2_NCK_1 | 52 | 56 | PF00017 | 0.664 |
LIG_SH2_SRC | 154 | 157 | PF00017 | 0.577 |
LIG_SH2_STAT3 | 156 | 159 | PF00017 | 0.668 |
LIG_SH2_STAT3 | 5 | 8 | PF00017 | 0.712 |
LIG_SH2_STAT5 | 144 | 147 | PF00017 | 0.734 |
LIG_SH2_STAT5 | 74 | 77 | PF00017 | 0.405 |
LIG_SH3_3 | 259 | 265 | PF00018 | 0.776 |
LIG_SH3_3 | 270 | 276 | PF00018 | 0.459 |
LIG_TRAF2_1 | 167 | 170 | PF00917 | 0.432 |
LIG_TRAF2_1 | 279 | 282 | PF00917 | 0.625 |
LIG_TYR_ITIM | 72 | 77 | PF00017 | 0.498 |
LIG_UBA3_1 | 290 | 296 | PF00899 | 0.706 |
MOD_CDK_SPxxK_3 | 145 | 152 | PF00069 | 0.699 |
MOD_CK1_1 | 138 | 144 | PF00069 | 0.654 |
MOD_CK1_1 | 228 | 234 | PF00069 | 0.721 |
MOD_CK1_1 | 47 | 53 | PF00069 | 0.592 |
MOD_CK2_1 | 226 | 232 | PF00069 | 0.759 |
MOD_CK2_1 | 276 | 282 | PF00069 | 0.720 |
MOD_GlcNHglycan | 197 | 201 | PF01048 | 0.612 |
MOD_GlcNHglycan | 258 | 262 | PF01048 | 0.693 |
MOD_GlcNHglycan | 34 | 37 | PF01048 | 0.705 |
MOD_GSK3_1 | 226 | 233 | PF00069 | 0.559 |
MOD_LATS_1 | 30 | 36 | PF00433 | 0.729 |
MOD_N-GLC_1 | 267 | 272 | PF02516 | 0.777 |
MOD_NEK2_1 | 225 | 230 | PF00069 | 0.499 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.425 |
MOD_NEK2_1 | 99 | 104 | PF00069 | 0.660 |
MOD_PKA_1 | 220 | 226 | PF00069 | 0.560 |
MOD_PKA_2 | 220 | 226 | PF00069 | 0.624 |
MOD_PKA_2 | 97 | 103 | PF00069 | 0.633 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.720 |
MOD_Plk_4 | 268 | 274 | PF00069 | 0.776 |
MOD_Plk_4 | 62 | 68 | PF00069 | 0.473 |
MOD_Plk_4 | 76 | 82 | PF00069 | 0.307 |
MOD_ProDKin_1 | 145 | 151 | PF00069 | 0.612 |
MOD_ProDKin_1 | 230 | 236 | PF00069 | 0.708 |
MOD_ProDKin_1 | 250 | 256 | PF00069 | 0.546 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.578 |
TRG_ENDOCYTIC_2 | 52 | 55 | PF00928 | 0.406 |
TRG_ENDOCYTIC_2 | 74 | 77 | PF00928 | 0.405 |
TRG_ER_diArg_1 | 139 | 142 | PF00400 | 0.661 |
TRG_ER_diArg_1 | 158 | 161 | PF00400 | 0.671 |
TRG_ER_diArg_1 | 212 | 214 | PF00400 | 0.612 |
TRG_ER_diArg_1 | 57 | 60 | PF00400 | 0.658 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4KL95 | Bodo saltans | 38% | 80% |
A0A3S7WPX5 | Leishmania donovani | 91% | 98% |
A4H530 | Leishmania braziliensis | 73% | 68% |
E9AL93 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |